Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy

Nephrology Dialysis Transplantation

Volumn 19, Issue 12, 2004, Pages 3062-3067

  Duncan, Neill ^a   Dhaygude, Ajay ^a   Owen, Jane ^a   Cairns, Thomas D H ^a   Griffith, Megan ^a   McLean, Adam G ^a   Palmer, Andrew ^a   Taube, David ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Focal segmental glomerulosclerosis; Nephrotic syndrome; Tacrolimus

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTEIN; TACROLIMUS; WARFARIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG OVERDOSE; DRUG POTENCY; DYSLIPIDEMIA; FEMALE; FOCAL GLOMERULONEPHRITIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LUNG EMBOLISM; MALE; MONOTHERAPY; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REMISSION; URINARY EXCRETION; URINARY TRACT INFECTION;

ADULT; ALBUMINURIA; CYCLOSPORINE; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROTEINURIA; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 11244299472     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh536     Document Type: Article

References (19)

1. Korbet S, Schwartz M, Lewis E. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 1994; 23: 773-783
2. Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH. The increased risk of coronary heart disease associated with the nephrotic syndrome. Kidney Int 1993; 44: 638-642
3. Peces R, Pobes A, Rodríguez M et al. Multiple venous thrombosis and massive pulmonary artery thrombus as the presenting features of steroid-responsive nephrotic syndrome. Nephrol Dial Transplant 1999; 14: 1306-1309
4. Ogi M, Yokoyama H, Tomosugi N et al. Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome. Am J Kidney Dis 1994; 24: 427-436
5. Myers BD, Boothroyd D, Olshen RA. Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and non-diabetic kidney disease. J Am Soc Nephrol 1998; 9 [Suppl 12]: S66-S70
6. Dogra GK, Watts GF, Herrmann S et al. Statin therapy improves brachial artery endothelial function in the nephrotic syndrome. Kidney Int 2002; 62: 550-557
7. Pei Y, Cattran D, Delmore T et al. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 1987; 82: 938-944
8. Ponticelli C et al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326-1332
9. Ponticelli C, Rizzoni G, Edefonti A et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993; 43: 1377-1384
10. Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 1999; 56: 2220-2226
11. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular injury. J Am Soc Nephrol 1991; 2 [Suppl 1]: S45-S52
12. FK506 Kidney Transplant Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-983
13. Klein IHHT, Abrahams A, van Ede T et al. Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation 2002; 73: 732-736
14. Segarra A, Vila J, Pou L et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 2002; 17: 655-662
15. McCauley J, Shapiro R, Ellis D et al. Pilot trial of FK506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993; 8: 1286-1290
16. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 2000; 11: A0828
17. Meyrier A, Noël L-H, Auriche P et al. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994; 45: 1446-1456
18. Selzner N, Durand F, Bernuau J et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. Transplantation 2001; 72: 1061-1065
19. Jurewicz WA. Tacrolimus versus cyclosporine immunosuppression: long-term outcome in renal transplantation. Nephrol Dial Transplant 2003; 18 [Suppl 1]: 7-11